Igor Keselman

BaroFold, Inc. develops and commercializes protein therapeutics. Its services include protein refolding, protein analytical and aggregate characterization, formulation stability and immunogenicity studies, and microbial expression. The company was founded by Matthew Seefeldt, Matthew Brewer, John F. Carpenter, Ted Randolph, Timothy C. Rodell, and Lyndal K. Hesterberg in 2009 and is headquartered in Aurora, CO.

Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA.

Part of Lumos Pharma, Inc., BioProtection Systems Corp. is a company that manufactures biological products. The company is based in Ames, IA.

University of Pittsburgh Medical Center is a non-profit organization, which engages in the provision of hospital health programs and services. It operates through the following business units: Provider Services, Insurance Services, UPMC International, and UPMC Enterprises. It also develops programs in transplantation, cancer, neurosurgery, psychiatry, orthopedics, and sports medicine. The company was founded in 1893 and is headquartered in Pittsburgh, PA.

Cook, Inc. develops healthcare devices. The company integrates minimally invasive medical device design, biopharma, gene and cell therapy, and biotech to enhance patient safety as well as improve clinical outcomes in the fields of aortic intervention, interventional cardiology, critical care medicine, gastroenterology, radiology, peripheral vascular, bone access & oncology, surgery and soft tissue repair, urology, and assisted reproductive technology, gynecology as well as high-risk obstetrics. The company is located in Bloomington, IN.

American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC.

Ilypsa, Inc. operates a biopharmaceutical firm. It develops renal care pharmaceutical products. The company was founded on March 6, 2003 and is headquartered in Thousand Oaks, CA.

Allegheny General Hospital, Inc. provides healthcare services. The firm offers traditional, medical, and surgical services as well as cardiology care and organ transplants. It also engages in research areas such as neuroscience, oncology, genetics, and trauma. The company was founded in 1885 and is headquartered in Pittsburgh, PA.

The American Association for the Advancement of Science provides science related journal, program, and education services. The firm also promotes the responsible use of science in public policy. The company was founded in 1848 and is headquartered in Washington, DC.

The American Institute of Chemical Engineers (AIChE) is a professional society with over 60,000 members in more than 110 countries. The private company is based in New York, NY, and has subsidiaries in the United States. AIChE offers various programs, including e-learning, webinars, and career advancement, to help chemical engineers at every career juncture bridge the skills gap created by the rush of technology, changing work styles, and unprecedented societal needs. Founded in 1908, AIChE is a focal point for information exchange on the frontiers of chemical engineering research in areas such as energy, sustainability, biological and environmental engineering, nanotechnology, and chemical plant safety and security.

Glens Falls Hospital, Inc. provides health care services. It offers hospital, surgical and community services, and outpatient care centers. The company was founded in 1897 and is headquartered in Glens Falls, NY.

The Controlled Release Society is a private company that focuses on providing fundamental delivery research, development, regulatory science, and clinical translation. The company is based in St. Paul, MN. The company was founded by Agis Kydonieus.

The American Academy of Anti-Aging Medicine, Inc. operates as a nonprofit organization that promotes the field of anti-aging medicine and trains and certifies physicians in this specialty. It engages in the advancement of technology to detect, prevent, and treat aging related disease and to promote research into methods to retard and optimize the human aging process. The company was founded by Ronald M. Klatz and Robert M. Goldman in 1992 and is headquartered in Boca Raton, FL.

Marvao Medical Devices Ltd. designs develop and markets novel medical devices. It provides products include NexSite 9Fr dual and NexSitetm 8Fr single lumen central venous catheters, as well as NexSite hemodialysis and drainage catheters. The company was founded by Christopher Davey and Mark A. Saab in 2006 and is headquartered in Dublin, Ireland.

Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL.

Harmonic Medical, Inc. develops non-invasive surgery treatment for uterine fibroids. It also treats broad range of cancer treatment such as bone metastases, metastic liver cancer, hepatocellular carcinoma, thyroid cancer, pancreatic cancer, and kidney cancer. The company is headquartered in Toronto, Canada.

Ashvattha Therapeutics LLC provides healthcare services. The firm develops pharmaceutical products. The company is headquartered in Redwood City, CA.

Orpheris, Inc. provides healthcare services. The firm focused on the treatment of neuroinflammatory orphan diseases. The company was founded was founded in 2015 and is headquartered in Redwood City, CA.

Digital Cognition Technologies, Inc. develops detect presymptomatic cognitive impairment and aid in tracking cognitive devices. The company was founded by Randall S. Davis, Dana L. Penney and Phil A. Cooper in 2015 and is headquartered in Waltham, MA.

NovaScan, Inc. engages in the development of a technology that electrically images objects. Its technology measures the electrical properties of materials. The firm focuses on breast cancer detection. The company was founded in 2001 by Larry Wells and William Gregory and is headquartered in Chicago, IL.

Hobbs Medical Ventures, LLC provides consulting services for the pharmaceutical industry. The private company is based in New York, NY. The company was founded by Eamonn P. Hobbs.

Elixirgen Therapeutics, Inc. operates as a biotechnology company. It develops and sells stem cell therapies for genetic diseases. The company was founded by Akihiro Ko and Minoru S. H. Ko in 2017 and is headquartered in Baltimore, MD.

ImPACT Applications, Inc. engages in the provision of concussion management solutions. Its products include ImPACT pediatric, ImPACT quick test, ImPACT passport, and ImPACT toolkit. The company was founded by Mark Lovell, Michael Collins, and Joseph Maroon in 2002 and is headquartered in Coralville, IA.

Syncromune, Inc. is a clinical-stage biopharmaceutical company that is dedicated to developing an in situ platform technology optimized for metastatic solid tumor cancers. The company is based in Fort Lauderdale, FL. The company is currently developing Sync-T™, a novel combination drug/device treatment platform that aims to achieve high response rates with potentially curative efficacy. The therapy is designed to synchronize in situ neoantigen T cell education and immunostimulation via intratumoral/locoregional infusion, with the goal of enabling the immune system to recognize and attack cancer throughout the body. The first two candidates, SV-101 and SV-102, are currently in investigator-initiated phase 1 trials. Link. The company was founded in 2020 by Charles J. Eamonn P. Hobbs has been the CEO of the company since 2020.